EcoDrugPlus

Transient Receptor Potential Cation Channel, Subfamily A, Member 1

Ensembl ID : ENSMAUG00000020258
Gene Symbol: TRPA1
1 Cross references
226 Possible Orthologues:

Translocator Protein

Ensembl ID : ENSMAUG00000022011
Gene Symbol: TSPO
4 Cross references
126 Possible Orthologues:

Transthyretin

Ensembl ID : ENSMAUG00000011770
Gene Symbol: TTR
4 Cross references
164 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSMAUG00000002337
Gene Symbol: TPH1
1 Cross references
255 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSMAUG00000010899
Gene Symbol: TUBA4A
4 Cross references
224 Possible Orthologues:

Tubulin Alpha-3 Chain

Ensembl ID : ENSMAUG00000000873
Gene Symbol: LOC101831620
3 Cross references
316 Possible Orthologues:

Tubulin Beta 1 Class Vi

Ensembl ID : ENSMAUG00000000615
Gene Symbol: TUBB1
3 Cross references
186 Possible Orthologues:

Tubulin Beta 3 Class Iii

Ensembl ID : ENSMAUG00000001598
Gene Symbol: TUBB3
4 Cross references
144 Possible Orthologues:

Tubulin Beta 4a Class Iva

Ensembl ID : ENSMAUG00000017901
Gene Symbol: TUBB4A
4 Cross references
94 Possible Orthologues:

Tubulin Beta 4b Class Ivb

Ensembl ID : ENSMAUG00000004730
Gene Symbol: TUBB4B
4 Cross references
316 Possible Orthologues:

Tubulin Beta 6 Class V

Ensembl ID : ENSMAUG00000000304
Gene Symbol: TUBB6
4 Cross references
141 Possible Orthologues:

Tubulin Beta Class I

Ensembl ID : ENSMAUG00000020031
Gene Symbol: TUBB
4 Cross references
292 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).